Description: Join TiE Austin for what promises to be an eye-opening and whip-smart webinar with True Wealth Venture’s Kerry Rupp interviewing Kiran Mazumdar-Shaw on July 29, 2020, at 10 am (US CDT) / 8:30 pm(IST).
A self-made billionaire – a first for a woman in India – Kiran Mazumdar-Shaw, follows a different model which combines a social worker’s empathy with a chief executive’s mindset. She calls her approach “Compassionate Capitalism”: using proven business strategies to build a durable foundation for sustainable social development.
Today, businesses have to account for what they impose on the environment, the communities that are proximate to their factories, plants, and offices, their employees whom they have to treat with more kindness, and the consumers and other stakeholders to whom they must be accountable. In other words, corporations must practice a capitalism that is more humane and compassionate, as well as just and fair.
On the other hand, there are those – and these may still be in the majority – who hold the traditional view that “business of business is business” and hence the “responsibility of business is business” and nothing else.
- What is Kiran’s point of view on this?
- How does she operate her business as a chief executive herself?
- How can a business’s strategies help you build a durable foundation – a foundation for sustainable social development?
- Can innovation and commerce be used to drive social progress? How?
- Can you practice empathy and still deliver grand monetary success in your business? How?
“When innovation and commerce are used to drive social progress”, says Kiran, “the implementation is a lot cheaper, many more people benefit, and the effect is longer”.
Kiran is a highly respected businesswoman and a global thought-leader in Biotechnology. Since the inception of Biocon in 1978 as an industrial enzyme company, Kiran has evolved the company to become a fully integrated, innovation-led, global biopharmaceutical enterprise committed to reducing therapy costs of chronic medical conditions such as diabetes, cancer, and autoimmune diseases.
As the EY World Entrepreneur of the Year 2020, Kiran is a global influence. She is ranked among the:
- World’s most influential people in Biopharma by Fierce Biotech, by Forbes Magazine;
- “Top 25 most powerful women in Asia-Pacific”, Fortune Magazine;
- “100 most influential people in the world”, Time Magazine;
- Among the “100 Leading Global Thinkers” by Foreign Policy magazine;
- Ranked No. 1 in the Business Captains category on ‘Medicine Maker Power List, 2018.
Importantly she has been recognized with a Padma Shri (1989) & Padma Bhushan (2005) – two of India’s most prestigious civilian honors.
She serves as a full-term member of the Board of Trustees of The MIT Corporation, USA.